Literature DB >> 8869748

Regulation of lipogenic enzyme expression by glucose in liver and adipose tissue: a review of the potential cellular and molecular mechanisms.

F Foufelle1, J Girard, P Ferré.   

Abstract

Regulation of gene expression by nutrients is an important part of the mechanisms allowing mammals to adapt to their nutritional environment. This is especially true for enzymes involved in the storage of energy such as the lipogenic and glycolytic enzymes in the liver and adipose tissue. We review in the present paper the cellular and molecular mechanisms involved in the regulation of glycolytic and lipogenic enzyme gene expression by glucose. In vivo and in vitro experiments have demonstrated that FAS and ACC gene expression is upregulated by glucose in adipose tissue, FAS, ACC and L-PK expression in the liver and ACC and L-PK expression in a pancreatic beta-cell line. This regulation involves the stimulation of their transcription. In order for glucose to act as a gene inducer, it must be metabolized. In adipose tissue, insulin increases indirectly the expression of FAS and ACC by stimulating glucose metabolism through its well-known effect on glucose transport. In the liver, the action of insulin is also indirect by allowing the expression of glucokinase and hence by increasing glucose metabolism. In the liver, fructose has a potentiating effect on the stimulation of gene expression by glucose through its stimulatory effect on glucokinase activity. Several evidences suggest that glucose-6-phosphate is the signal metabolite: (i) the effect of glucose is mimicked by 2-deoxyglucose (a glucose analogue whose metabolism stops after its phosphorylation by hexokinase) in adipose tissue and beta-cell line but not in the liver in which 2-deoxyglucose-6-phosphate does not accumulate, (ii) intracellular glucose-6-phosphate concentration varies in parallel with ACC, FAS and L-PK mRNA concentrations in liver, adipose tissue and beta-cell line, (iii) in vivo, the kinetics of hexose-phosphate fits with the time-related pattern of gene induction. Glucose response elements have been characterized on three genes, L-PK, S14 (a gene which codes for a protein of unknown function but which is directly related to lipogenesis) and FAS. These glucose response elements have all in common the presence of a sequence 5'-CACGTG-3' which binds a transcription factor of the basic domain, helix-loop-helix, leucine zipper family called USF/MLTF, although the organization of the overall glucose response element probably differs from one gene to another. The mechanisms linking glucose-6-phosphate to the glucose responsive transcription complex are presently largely unknown.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8869748     DOI: 10.1016/0065-2571(95)00010-0

Source DB:  PubMed          Journal:  Adv Enzyme Regul        ISSN: 0065-2571


  14 in total

1.  Spot 14 protein interacts and co-operates with chicken ovalbumin upstream promoter-transcription factor 1 in the transcription of the L-type pyruvate kinase gene through a specificity protein 1 (Sp1) binding site.

Authors:  E Compe; G de Sousa; K François; R Roche; R Rahmani; J Torresani; M Raymondjean; R Planells
Journal:  Biochem J       Date:  2001-08-15       Impact factor: 3.857

2.  Glucagon-like peptide-1 inhibits adipose tissue macrophage infiltration and inflammation in an obese mouse model of diabetes.

Authors:  Y-S Lee; M-S Park; J-S Choung; S-S Kim; H-H Oh; C-S Choi; S-Y Ha; Y Kang; Y Kim; H-S Jun
Journal:  Diabetologia       Date:  2012-06-22       Impact factor: 10.122

3.  Patatin-like phospholipase domain-containing 3/adiponutrin deficiency in mice is not associated with fatty liver disease.

Authors:  Weiqin Chen; Benny Chang; Lan Li; Lawrence Chan
Journal:  Hepatology       Date:  2010-09       Impact factor: 17.425

4.  Transcriptome meta-analysis reveals dysregulated pathways in nasopharyngeal carcinoma.

Authors:  Warut Tulalamba; Noppadol Larbcharoensub; Ekaphop Sirachainan; Aunchalee Tantiwetrueangdet; Tavan Janvilisri
Journal:  Tumour Biol       Date:  2015-02-28

5.  Induction of fatty acid synthase and S14 gene expression by glucose, xylitol and dihydroxyacetone in cultured rat hepatocytes is closely correlated with glucose 6-phosphate concentrations.

Authors:  F Mourrieras; F Foufelle; M Foretz; J Morin; S Bouche; P Ferre
Journal:  Biochem J       Date:  1997-09-01       Impact factor: 3.857

6.  Genome-wide transcriptome expression in the liver of a mouse model of high carbohydrate diet-induced liver steatosis and its significance for the disease.

Authors:  Ion V Deaciuc; Zhenyuan Song; Xuejun Peng; Shirish S Barve; Ming Song; Qiang He; Thomas B Knudsen; Amar V Singh; Craig J McClain
Journal:  Hepatol Int       Date:  2007-11-27       Impact factor: 6.047

7.  The n-3 long-chain PUFAs modulate the impact of the GCKR Pro446Leu polymorphism on triglycerides in adolescents.

Authors:  Julien Rousseaux; Alain Duhamel; Julie Dumont; Jean Dallongeville; Denes Molnar; Kurt Widhalm; Yannis Manios; Michael Sjöström; Anthony Kafatos; Christina Breidenassel; Marcela Gonzales-Gross; Magdalena Cuenca-Garcia; Laura Censi; Marcos Ascensión; Stefaan De Henauw; Luis A Moreno; Aline Meirhaeghe; Frédéric Gottrand
Journal:  J Lipid Res       Date:  2015-07-01       Impact factor: 5.922

8.  Mice without the regulator gene Rsc1A1 exhibit increased Na+-D-glucose cotransport in small intestine and develop obesity.

Authors:  Christina Osswald; Katharina Baumgarten; Frank Stümpel; Valentin Gorboulev; Marina Akimjanova; Klaus-Peter Knobeloch; Ivan Horak; Reinhart Kluge; Hans-Georg Joost; Hermann Koepsell
Journal:  Mol Cell Biol       Date:  2005-01       Impact factor: 4.272

9.  Nutritional and insulin regulation of fatty acid synthetase and leptin gene expression through ADD1/SREBP1.

Authors:  J B Kim; P Sarraf; M Wright; K M Yao; E Mueller; G Solanes; B B Lowell; B M Spiegelman
Journal:  J Clin Invest       Date:  1998-01-01       Impact factor: 14.808

10.  Gene expression meta-analysis identifies metastatic pathways and transcription factors in breast cancer.

Authors:  Mads Thomassen; Qihua Tan; Torben A Kruse
Journal:  BMC Cancer       Date:  2008-12-30       Impact factor: 4.430

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.